Research Overview

The Managed Oncology Service offers insights, analyses and recommendations specific to oncology focused on manufacturer value-added programming, account management support, patients’ cost burden, and developing management trends, such as clinical pathways. 

Annual research provides detailed data on US health plans’ management of oncolytics and the implications of underlying market trends. The service focuses on the following research areas:

• patient cost sharing
• physician reimbursement
• quality of oncology account managers and clinical liaisons
• ratings of valued partners in oncology management 

Who Should Subscribe?

• Market researchers
• Sales and marketing executives
• Employer, payer, and corporate account managers and directors
• Product managers 
• National and regional account management teams that want to expand their understanding of the priorities of employers and managed care organizations
• All others doing business in the managed markets, market access, or managed care space

Why Subscribe?

HIRC research assists sales and marketing executives in developing strategic responses to the evolution of health plans’ management of oncology drugs. The Managed Oncology Service provides comprehensive analyses of managed care trends in the management of cancer agents. The service marries detailed survey data with in-depth interviews of health plan pharmacy and medical directors, providing rich and nuanced analyses of current and expected approaches to the management of oncolytics. In addition, the research includes benchmark data from manufacturers' value-added programming specific to oncology and identifies potential opportunities for manufacturer partnerships.